# Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

> **NCT00203463** · PHASE4 · COMPLETED · sponsor: **Tuscaloosa Research & Education Advancement Corporation** · enrollment: 40 (—)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00203463
- **Lead sponsor:** Tuscaloosa Research & Education Advancement Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 40 (—)
- **Last updated:** 2009-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203463, "Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT00203463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*